Literature DB >> 4624138

Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.

P Dombernowsky, N I Nissen, V Larsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4624138

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  9 in total

Review 1.  VM26: phase I and II studies.

Authors:  F R Macbeth
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  VM26 therapy in children with drug-refractory lymphocytic leukemia.

Authors:  G Rivera; G V Dahl; S B Murphy; W P Bowman; R J Aur; T L Avery; J V Simone
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Effects of monocytopenia and anticoagulation in experimental Streptococcus sanguis endocarditis.

Authors:  L Thörig; J Thompson; F Eulderink; J J Emeis; R Van Furth
Journal:  Br J Exp Pathol       Date:  1980-02

4.  VM-26 in colorectal carcinoma: a Southwest Oncology Group study.

Authors:  N Oishi; T R Fleming; L Laufman; J S Ungerleider; R B Natale; A B Einstein; D D Von Hoff; J S Macdonald
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

Review 5.  The podophyllotoxin derivatives VP16-213 and VM26.

Authors:  B F Issell
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.

Authors:  R T Dorr; D S Alberts
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

Review 7.  The clinical pharmacology of etoposide and teniposide.

Authors:  P I Clark; M L Slevin
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

Review 8.  Teniposide: overview of its therapeutic potential in adult cancers.

Authors:  F M Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].

Authors:  H J Schmoll; N Niederle; W Achterrath
Journal:  Klin Wochenschr       Date:  1981-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.